March FDA events

                                  March FDA events

This is a list of biotech company's upcoming events that I will be keeping an eye on.

 DEPO   Advisory committee meeting on the 03/04/13

NRIFF  PDUFA date for Pennsail on 03/04/13

THRX   Advisory committee meeting on the 03/07/13

ANAC   Phase 3 result of Tavaborole out around the 3/12/13

TTNP   Advisory committee meeting on the 03/21/13

APPA   PDUFA date for APF530 on 3/27/13

 ZIOP  Phase 3 result of palifosfamide around the 03/29/13

ACRX  Phase 3 result of Sufentanil around the 03/31/13

ALIM  Will be resubmitting the NDA for lluvien around the 03/31/13

CYCC Phase 3 results for Sapacitabine around the 03/31/13

IGXT NDA filing for Rizatriptan on 03/31/13